PAPADOPOULOS STELIOS

Director at SGX PHARMACEUTICALS, INC. · on record since Jan 31, 2006
Director at GENVEC INC · on record since Jun 26, 2006
Director at EXELIXIS, INC. · on record since May 3, 2006
Director at ANADYS PHARMACEUTICALS INC · on record since Jun 2, 2006
Director at BIOGEN INC. · on record since Jul 9, 2008
Director at Decarbonization Plus Acquisition Corp II · on record since Aug 25, 2003
Director at BG Medicine, Inc. · on record since Feb 11, 2011
Director at Ovid Therapeutics Inc. · on record since Apr 9, 2026
Director at Regulus Therapeutics Inc. · on record since Oct 4, 2012
Director at Eucrates Biomedical Acquisition Corp. · on record since Nov 27, 2020
10% owner at Eucrates Biomedical Acquisition Corp. · on record since Nov 27, 2020

Insider trading activity of PAPADOPOULOS STELIOS

Transactions on record: 298; since Aug 25, 2003

Open-market buys: 54; $9.8M

Open-market sells: 33; $25.3M

Companies traded: 10; last filing May 29, 2026

Figures computed from official regulatory filings — .

Companies where PAPADOPOULOS STELIOS has traded

EXELIXIS, INC.111 tx · $21.3M · May 29, 2026
Ovid Therapeutics Inc.3 tx · $45K · Apr 9, 2026
Regulus Therapeutics Inc.67 tx · $6.6M · Jun 27, 2025
BIOGEN INC.32 tx · $14.3M · Jun 17, 2022
Eucrates Biomedical Acquisition Corp.1 tx · Nov 27, 2020
54 tx · $1.6M · Nov 20, 2015
16 tx · $1.3M · May 27, 2011
4 tx · Jun 26, 2006
4 tx · Feb 7, 2006
6 tx · Aug 25, 2003

Track record of PAPADOPOULOS STELIOS

Statistical track record

Free account

Open-market buys: 59

Last buy: May 7, 2019

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of PAPADOPOULOS STELIOS

Co-insiders of PAPADOPOULOS STELIOS

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
EXELIXIS, INC.Listing on record	May 29, 2026	Award	8,367	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ovid Therapeutics Inc.Listing on record	Apr 9, 2026	Award	17,578	2.56 USD	$45K		SEC
Ovid Therapeutics Inc.Listing on record	Mar 2, 2026	AwardD (derivative)	65,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	Nov 13, 2025	Sell	-100,000	43.55 USD	$4.4M	Unusual size	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-59,514	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-2,325	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,650	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-976,253	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-64,635	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-9,000	—	n/a (No price was disclosed in the filing)		SEC
EXELIXIS, INC.Listing on record	May 30, 2025	Award	9,812	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	ExerciseD (derivative)	-15,874	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Exercise	15,874	20.50 USD	$325.4K		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Sell	-20,634	44.35 USD	$915.1K		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Exercise	20,634	19.77 USD	$407.9K		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	ExerciseD (derivative)	-20,634	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Sell	-15,874	44.35 USD	$704K		SEC
Regulus Therapeutics Inc.Listing unverified	Apr 30, 2025	Award	62,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ovid Therapeutics Inc.Listing on record	Mar 4, 2025	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	Jun 4, 2024	Award	18,838	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
EXELIXIS, INC.Listing on record	May 29, 2026	Award	8,367	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ovid Therapeutics Inc.Listing on record	Apr 9, 2026	Award	17,578	2.56 USD	$45K		SEC
Ovid Therapeutics Inc.Listing on record	Mar 2, 2026	AwardD (derivative)	65,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	Nov 13, 2025	Sell	-100,000	43.55 USD	$4.4M	Unusual size	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-59,514	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-2,325	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,650	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-976,253	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-64,635	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-9,000	—	n/a (No price was disclosed in the filing)		SEC
EXELIXIS, INC.Listing on record	May 30, 2025	Award	9,812	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	ExerciseD (derivative)	-15,874	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Exercise	15,874	20.50 USD	$325.4K		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Sell	-20,634	44.35 USD	$915.1K		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Exercise	20,634	19.77 USD	$407.9K		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	ExerciseD (derivative)	-20,634	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	May 16, 2025	Sell	-15,874	44.35 USD	$704K		SEC
Regulus Therapeutics Inc.Listing unverified	Apr 30, 2025	Award	62,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ovid Therapeutics Inc.Listing on record	Mar 4, 2025	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
EXELIXIS, INC.Listing on record	Jun 4, 2024	Award	18,838	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC